In recent years, the global bovine gelatin powder market has faced a serious shortage crisis, which has not only affected the health care and food industries, but also had a profound impact on the pharmaceutical and cosmetics industries. Supply chain disruptions, fluctuations in raw material supply, and geopolitical factors are the main causes of this crisis.
Analysis of shortage causes
Fluctuations in raw material supply
The main raw materials for bovine gelatin powder are cattle bones and cowhides. The supply of these raw materials is significantly affected by the livestock production cycle, animal diseases, and international trade policies. In addition, adjustments to livestock policies and export restrictions in some countries have also exacerbated the problem of raw material shortages.
Geopolitics and trade restrictions
Geopolitical factors have a significant impact on the supply of bovine gelatin powder. For example, the European and American markets have high requirements for pure bovine gelatin, but domestic raw material suppliers find it difficult to guarantee the absolute purity of bovine bone particles, resulting in a large reliance on imports. At the same time, international trade frictions and tariff policies have also increased the procurement cost of raw materials.
Environmental protection and policy restrictions
With the increase in environmental awareness, the government has continuously increased its supervision of environmental issues such as wastewater and waste gas emissions in the gelatin production process. This has put some companies at risk of suspension of production or high fines, further affecting the supply of bovine gelatin powder.
Industry response strategies
Find alternatives
Many companies have begun to look for alternatives to bovine gelatin powder to cope with the shortage of raw materials. For example, some companies have turned to plant glue (such as agar, pectin) or synthetic glue to replace bovine gelatin powder. In addition, fish collagen, as a sustainable alternative, has also gradually gained attention in the market.
Adjusting formula and product design
In response to the shortage of bovine gelatin powder, some companies have reduced their dependence on bovine gelatin powder by adjusting product formulas. For example, in the production of pharmaceutical capsules, some companies have begun to use plant-based materials such as hydroxypropyl methylcellulose (HPMC) to replace traditional bovine gelatin.
Optimizing supply chain management
Companies improve the efficiency of raw material procurement by optimizing supply chain management. For example, Deyang Customs has helped companies introduce high-quality bovine bone granule resources from foreign countries such as Bangladesh and Pakistan through policy guidance and assistance, which has greatly reduced the cost of raw materials.
Future price trends and industry impacts
Price fluctuations
Due to the unstable supply of raw materials and rising production costs, the price of bovine gelatin powder is expected to continue to fluctuate. Companies need to pay close attention to market dynamics and flexibly adjust their procurement strategies.
Emerging Market Opportunities
Despite the challenges, the growing demand in emerging markets has also brought new opportunities to the bovine gelatin powder industry. For example, the growing market demand in the Asia-Pacific region and Latin America has provided new market space for companies.
The global bovine gelatin powder shortage crisis has had a profound impact on the health care products, food, pharmaceutical and cosmetics industries. Companies need to respond to this challenge by finding alternatives, optimizing supply chain management, and adjusting product formulas. At the same time, paying attention to market dynamics and policy changes and flexibly adjusting business strategies will be the key for companies to remain competitive in this crisis.
The impact of bovine gelatin powder shortage on drug prices
In recent years, the global bovine gelatin powder market has faced a serious shortage problem, which has had a significant impact on drug prices. Bovine gelatin powder is an indispensable and important raw material in the production of pharmaceutical capsules. Its shortage not only leads to an increase in production costs, but also affects the market supply and price of drugs. The following is an analysis of the specific impact of the shortage of bovine gelatin powder on drug prices:
1. Rising raw material prices
The shortage of bovine gelatin powder has directly led to a sharp increase in its price. According to market analysis, the price of medicinal gelatin raw materials has risen by 20% recently, and the purchase price has risen by 10%. This price increase has increased the cost of pharmaceutical manufacturers, which in turn has driven up drug prices.
2. Increased production costs
Due to the shortage of bovine gelatin powder, pharmaceutical capsule manufacturers have to look for alternative materials or adjust production processes. Although these alternative materials have alleviated the problem of raw material shortage to a certain extent, their cost is usually higher than that of traditional bovine gelatin powder, further increasing production costs.
3. Limited drug supply
The shortage of bovine gelatin powder has led to insufficient supply of pharmaceutical capsules, affecting the normal production of drugs. Many pharmaceutical capsule manufacturers are facing the dilemma of raw material shortages, resulting in delays in production plans and even the inability of some drugs to be produced on time. This limited supply situation not only affects the economic benefits of pharmaceutical companies, but may also lead to an imbalance in supply and demand in the pharmaceutical market, further pushing up drug prices.
Post time: Apr-18-2025